Log In
BCIQ
Print this Print this
 

HBIG

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionHepatitis B immunoglobulin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHepatitis B virus (HBV)
Indication DetailsPrevent hepatitis B virus (HBV) re-infection of the liver
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today